[go: up one dir, main page]

AU2012305807B2 - Dengue-virus serotype neutralizing antibodies - Google Patents

Dengue-virus serotype neutralizing antibodies

Info

Publication number
AU2012305807B2
AU2012305807B2 AU2012305807A AU2012305807A AU2012305807B2 AU 2012305807 B2 AU2012305807 B2 AU 2012305807B2 AU 2012305807 A AU2012305807 A AU 2012305807A AU 2012305807 A AU2012305807 A AU 2012305807A AU 2012305807 B2 AU2012305807 B2 AU 2012305807B2
Authority
AU
Australia
Prior art keywords
seq
cdr2
cdr1
cdr3
cdr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2012305807A
Other languages
English (en)
Other versions
AU2012305807A8 (en
AU2012305807A1 (en
Inventor
Atchareeya A-nuegoonpipat
Surapee Anantapreecha
Panadda Dhepakson
Kazuyoshi Ikuta
Motoki Kuhara
Yoshinobu Okuno
Prawatsilpa Pattarin
Apichai Prachasuphap
Pongrama Ramasoota
Tadahiro Sasaki
Pathom Sawanpanyalert
Chayanee Setthapramote
Aree Thattiyaphong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical and Biological Laboratories Co Ltd
University of Osaka NUC
Department of Medical Sciences (DMSc)
Mahidol University
Original Assignee
Medical and Biological Laboratories Co Ltd
Osaka University NUC
Department OF MEDICAL SCIENCES DMSC
Mahidol University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical and Biological Laboratories Co Ltd, Osaka University NUC, Department OF MEDICAL SCIENCES DMSC, Mahidol University filed Critical Medical and Biological Laboratories Co Ltd
Publication of AU2012305807A1 publication Critical patent/AU2012305807A1/en
Publication of AU2012305807A8 publication Critical patent/AU2012305807A8/en
Application granted granted Critical
Publication of AU2012305807B2 publication Critical patent/AU2012305807B2/en
Assigned to OSAKA UNIVERSITY, MAHIDOL UNIVERSITY, MEDICAL AND BIOLOGICAL LABORATORIES CO., LTD, Department of Medical Sciences (DMSc) reassignment OSAKA UNIVERSITY Request for Assignment Assignors: Department of Medical Sciences (DMSc), MAHIDOL UNIVERSITY, MEDICAL AND BIOLOGICAL LABORATORIES CO., LTD, OSAKA UNIVERSITY, THE RESEARCH FOUNDATION FOR MICROBIAL DISEASES OF OSAKA UNIVERSITY
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2012305807A 2011-09-09 2012-09-07 Dengue-virus serotype neutralizing antibodies Active AU2012305807B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161532605P 2011-09-09 2011-09-09
US201161532671P 2011-09-09 2011-09-09
US61/532,671 2011-09-09
US61/532,605 2011-09-09
PCT/JP2012/005699 WO2013035345A2 (fr) 2011-09-09 2012-09-07 Anticorps neutralisant les sérotypes du virus de la dengue

Publications (3)

Publication Number Publication Date
AU2012305807A1 AU2012305807A1 (en) 2014-02-20
AU2012305807A8 AU2012305807A8 (en) 2014-03-13
AU2012305807B2 true AU2012305807B2 (en) 2015-08-20

Family

ID=47116163

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012305807A Active AU2012305807B2 (en) 2011-09-09 2012-09-07 Dengue-virus serotype neutralizing antibodies

Country Status (5)

Country Link
AU (1) AU2012305807B2 (fr)
MY (1) MY170725A (fr)
PH (1) PH12014500544B1 (fr)
SG (1) SG11201400100SA (fr)
WO (1) WO2013035345A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6764348B2 (ja) 2014-02-11 2020-09-30 ビステラ， インコーポレイテッド デングウイルスに対する抗体分子およびその使用
CN105137068B (zh) * 2015-07-24 2017-03-01 鲁东大学 氟苯尼考现场检测试纸及其制备、使用方法
CN105004860B (zh) * 2015-07-24 2016-09-21 鲁东大学 氟苯尼考快速检测试剂盒及其制备、使用方法
WO2017165736A1 (fr) 2016-03-25 2017-09-28 Visterra, Inc. Formulations de molécules d'anticorps contre le virus de la dengue
CN109929033B (zh) * 2019-03-15 2020-06-02 中国人民解放军军事科学院军事医学研究院 一种特异性结合四种血清型登革病毒的人源抗体

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010043977A2 (fr) * 2008-10-13 2010-04-22 Institute For Research In Biomedicine Anticorps de neutralisation du virus de la dengue et leurs utilisations
WO2010093335A1 (fr) * 2009-02-10 2010-08-19 Nanyang Technological University Anticorps destinés au diagnostic et au traitement d'infections flavivirales

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450150A (en) 1973-05-17 1984-05-22 Arthur D. Little, Inc. Biodegradable, implantable drug delivery depots, and method for preparing and using the same
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4741900A (en) 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5169939A (en) 1985-05-21 1992-12-08 Massachusetts Institute Of Technology & Pres. & Fellows Of Harvard College Chimeric antibodies
GB8800077D0 (en) 1988-01-05 1988-02-10 Ciba Geigy Ag Novel chimeric antibodies
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5859205A (en) 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
US6800738B1 (en) 1991-06-14 2004-10-05 Genentech, Inc. Method for making humanized antibodies
CA2078539C (fr) 1991-09-18 2005-08-02 Kenya Shitara Procede de fabrication de chimere d'anticorps humain
EP1136556B1 (fr) 1991-11-25 2005-06-08 Enzon, Inc. Procédé pour produire de protéines multivalents de fixation de l'antigène
US6042828A (en) 1992-09-07 2000-03-28 Kyowa Hakko Kogyo Co., Ltd. Humanized antibodies to ganglioside GM2
PT752248E (pt) 1992-11-13 2001-01-31 Idec Pharma Corp Aplicacao terapeutica de anticorpos quimericos e marcados radioactivamente contra antigenios de diferenciacao restrita de linfocitos b humanos para o tratamento do linfoma de celulas b
DE4337197C1 (de) 1993-10-30 1994-08-25 Biotest Pharma Gmbh Verfahren zur selektiven Herstellung von Hybridomazellinien, die monoklonale Antikörper mit hoher Zytotoxizität gegen humanes CD16-Antigen produzieren, sowie Herstellung bispezifischer monoklonaler Antikörper unter Verwendung derartiger monoklonaler Antikörper und des CD30-HRS-3-Antikörpers zur Therapie menschlicher Tumore
WO1998047343A2 (fr) 1997-04-04 1998-10-29 Biosite Diagnostics, Inc. Bibliotheques polyvalentes et polyclonales
EP1597280B2 (fr) * 2003-02-26 2016-08-24 Institute for Research in Biomedicine Production d'anticorps monoclonaux par transformation de lymphocytes b par le virus d'epstein barr
CN101466828B (zh) * 2006-04-13 2011-12-21 株式会社医学生物学研究所 融合伴侣细胞
EP2144931A2 (fr) * 2007-04-04 2010-01-20 The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services Anticorps monoclonaux contre le virus de la dengue et d'autres virus avec délétion dans la région fc
WO2010073647A1 (fr) * 2008-12-25 2010-07-01 国立大学法人大阪大学 Anticorps humain anti-virus de la grippe humaine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010043977A2 (fr) * 2008-10-13 2010-04-22 Institute For Research In Biomedicine Anticorps de neutralisation du virus de la dengue et leurs utilisations
WO2010093335A1 (fr) * 2009-02-10 2010-08-19 Nanyang Technological University Anticorps destinés au diagnostic et au traitement d'infections flavivirales

Also Published As

Publication number Publication date
WO2013035345A2 (fr) 2013-03-14
MY170725A (en) 2019-08-27
AU2012305807A8 (en) 2014-03-13
SG11201400100SA (en) 2014-06-27
PH12014500544B1 (en) 2019-03-13
PH12014500544A1 (en) 2014-04-21
WO2013035345A3 (fr) 2013-09-06
AU2012305807A1 (en) 2014-02-20

Similar Documents

Publication Publication Date Title
US11912757B2 (en) Antibodies specifically binding to Zika virus epitopes and uses thereof
US11505597B2 (en) Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof
US9181328B2 (en) Human monoclonal antibodies broadly protective against influenza B virus and methods of using the same
US7750123B2 (en) Antibodies against SARS-CoV and methods of use thereof
JP6035332B2 (ja) Ａ型インフルエンザウイルス中和抗体及びその使用法
CA2731686C (fr) Anticorps neutralisant anti-virus influenza a et leurs utilisations
US8518408B2 (en) Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis C virus infection
KR102668588B1 (ko) 인간화된 인플루엔자 모노클로날 항체 및 그의 사용 방법
WO2017181098A2 (fr) Molécules d'anticorps se liant au virus zika et leurs utilisations
BRPI0914012A2 (pt) anticorpo humano, composição farmacêutica, molécula de ácido nucléico, célula, clone de célula b imortalizado, polipeptídeo imunogênico isolado ou purificado, método de inibição da infecção pelo vírus da dengue. método de tratamento da infecção pelo vírus da dengue, método de triagem de polipeptídeos, método monitoramento da qualidade das vascinas contra o vírus da dengue, vacina, uso do anticorpo e epítopo
TW201815821A (zh) 抗茲卡病毒抗體及使用方法
US11834494B2 (en) Antibodies to zika virus and methods of use thereof
BR112020000619A2 (pt) anticorpos multiespecíficos que se ligam especificamente a epítopos do zika vírus e usos dos mesmos
AU2012305807B2 (en) Dengue-virus serotype neutralizing antibodies
CN109641955A (zh) 人源化抗claudin-1抗体及其用途
CN113874394A (zh) 抗体
US20220332800A1 (en) Novel anti-zika virus antibodies and uses thereof
WO2014034127A1 (fr) Anticorps monoclonaux humains se liant à la neurotoxine botulique de type b et la neutralisant
US20210054055A1 (en) Highly specific zika neutralizing human antibodies
JP2020048568A (ja) Ａ型インフルエンザウイルス中和抗体及びその使用法
JP2017086068A (ja) Ａ型インフルエンザウイルス中和抗体及びその使用法
WO2021050989A1 (fr) Anticorps zika et leur utilisation
US20160264648A1 (en) Antibody having broad neutralization activity against group 1 influenza a viruses
JP2018110581A (ja) Ａ型インフルエンザウイルス中和抗体及びその使用法
HK40002097A (en) Novel antibodies specifically binding to zika virus epitopes and uses thereof

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 28 , NO 7 , PAGE(S) 975 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME OSAKA UNIVERSITY; MAHIDOL UNIVERSITY; DEPARTMENT OF MEDICAL SCIENCES (DMSC); THE RESEARCH FOUNDATION FOR MICROBIAL DISEASES OF OSAKA UNIVERSITY; MEDICAL AND BIOLOGICAL LABORATORIES CO., LTD, APPLICATION NO. 2012305807, UNDER INID (72), ADD CO-INVENTOR PATTARIN, PRAWATSILPA

FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: OSAKA UNIVERSITY

Free format text: FORMER OWNER(S): MAHIDOL UNIVERSITY; OSAKA UNIVERSITY; THE RESEARCH FOUNDATION FOR MICROBIAL DISEASES OF OSAKA UNIVERSITY; DEPARTMENT OF MEDICAL SCIENCES (DMSC); MEDICAL AND BIOLOGICAL LABORATORIES CO., LTD

Owner name: MAHIDOL UNIVERSITY

Free format text: FORMER OWNER(S): MAHIDOL UNIVERSITY; OSAKA UNIVERSITY; THE RESEARCH FOUNDATION FOR MICROBIAL DISEASES OF OSAKA UNIVERSITY; DEPARTMENT OF MEDICAL SCIENCES (DMSC); MEDICAL AND BIOLOGICAL LABORATORIES CO., LTD

Owner name: MEDICAL AND BIOLOGICAL LABORATORIES CO., LTD

Free format text: FORMER OWNER(S): MAHIDOL UNIVERSITY; OSAKA UNIVERSITY; THE RESEARCH FOUNDATION FOR MICROBIAL DISEASES OF OSAKA UNIVERSITY; DEPARTMENT OF MEDICAL SCIENCES (DMSC); MEDICAL AND BIOLOGICAL LABORATORIES CO., LTD

Owner name: DEPARTMENT OF MEDICAL SCIENCES (DMSC)

Free format text: FORMER OWNER(S): MAHIDOL UNIVERSITY; OSAKA UNIVERSITY; THE RESEARCH FOUNDATION FOR MICROBIAL DISEASES OF OSAKA UNIVERSITY; DEPARTMENT OF MEDICAL SCIENCES (DMSC); MEDICAL AND BIOLOGICAL LABORATORIES CO., LTD